FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
Sponsors
Adams Clinical
Conditions
Major Depressive Disorder
Unknown Phase
Tracking Response to Antidepressants in Advance of Investigational Trials
NCT04748276
Start: 2019-01-02End: 2023-12-31Target: 400Updated: 2023-03-27
Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study
CompletedNCT04933630
Start: 2021-06-01End: 2022-10-05Updated: 2023-03-27